Logo
NON-SMALL CELL LUNG CANCER MARKET ANALYSIS
  2. / Market Insights
  3. Non-Small Cell Lung Cancer Market Analysis
all report title image

NON-SMALL CELL LUNG CANCER MARKET ANALYSIS

Non-Small Cell Lung Cancer Market, By Type (Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma, Large Cell Neuroendocrine Tumors), By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Others), By End User (Hospitals, Homecare, Specialty Clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Jun 2024
  • Code : CMI241
  • Pages :175
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Non-Small Cell Lung Cancer Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • F. Hoffmann-La Roche Ltd
  • Honeywell International Inc.
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Eli Lilly and Company
  • Boehringer Ingelheim International GmbH
  • Celgene Corporation
  • Amgen Inc.
  • Johnson & Johnson
  • Gilead Sciences, Inc.
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Takeda Pharmaceutical Company Limited
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

Non-Small Cell Lung Cancer Market to surpass US$ 49.11 Bn by 2031
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.